Atlas Trials

LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

Clinical trial NCT00833872 · COMPLETED

Trial details

NCT number
NCT00833872
Sponsor
LEO Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Psoriasis Vulgaris
Start date
2009-01-01
Primary completion
2009-10-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.